Details for New Drug Application (NDA): 021375
The generic ingredient in ALAVERT is loratadine. There is one drug master file entry for this compound. One hundred and fifty-two suppliers are listed for this compound. Additional details are available on the loratadine profile page.
Summary for 021375
| Tradename: | ALAVERT |
| Applicant: | Fdn Consumer |
| Ingredient: | loratadine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021375
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 10MG | ||||
| Approval Date: | Dec 19, 2002 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
